Update in asthma 2009.
Center for Genomics and Personalized Medicine and Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA. wmoore@wfubmc.edu
Wendy C
WC
Moore
Rodolfo M
RM
Pascual
D000445:Aldehyde Oxidoreductases / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy* / Q000235:genetics* / Q000276:immunology; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D004198:Disease Susceptibility; D005764:Gastroesophageal Reflux / Q000150:complications / Q000188:drug therapy; D006801:Humans; D056747:Immunomodulation; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D018418:Th2 Cells / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014807:Vitamin D / Q000097:blood
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D007252:Influenza Vaccines; D015848:Interleukin-5; D054328:Proton Pump Inhibitors; D014409:Tumor Necrosis Factor-alpha; D014807:Vitamin D; D000445:Aldehyde Oxidoreductases; C087006:formaldehyde dehydrogenase, glutathione-independent